EMCDDA, Lisbon, December 2020
Summary
The purpose of these guidelines is to ensure compliance with the scope and requirements of Regulation (EC) No 1920/2006 (as amended) and Council Framework Decision 2004/757/JHA (as amended) in respect to the risk assessment procedure for and reporting on new psychoactive substances.
To operationalise the technical aspects of the risk assessment, the guidelines are supported by a set of Guidance notes developed by the EMCDDA. The Guidance notes will be adapted as required in order to reflect developments in the field of new psychoactive substances and risk assessment.
Table of contents
- Introduction and purpose
- Legal basis and scope
- Conceptual framework for risk assessment
- General considerations for risk assessment
- Risk assessment report
- References
Guidance notes
Main subject:
Follow this news feed: EU